Impact of the COVID-19 pandemic on eye strain and dry eye symptoms
Autor: | Prabjot Channa, Matthew Makara, Rebecca Petris, Ian J. Saldanha, Esen K. Akpek |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Adult
2019-20 coronavirus outbreak Pediatrics medicine.medical_specialty Coronavirus disease 2019 (COVID-19) genetic structures Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Visual function Eye pain Dry eye Eye symptoms Article 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Pandemic medicine Humans 030212 general & internal medicine Pandemics business.industry SARS-CoV-2 COVID-19 eye diseases Difficulty concentrating Ophthalmology Reading 030221 ophthalmology & optometry Dry Eye Syndromes sense organs business Eye strain |
Zdroj: | The Ocular Surface |
ISSN: | 1937-5913 1542-0124 |
Popis: | Purpose Among adult individuals with dry eye, assess the self-reported impact of the COVID-19 pandemic on (1) dry eye-related visual function, (2) reading efficiency, and (3) dry eye treatments used. Methods In June–July 2020, we conducted an online survey of adults with dry eye who spent at least somewhat more time at home during the pandemic than before. Consistent with TFOS DEWS II guidelines, we categorized respondents into mild, moderate, or severe dry eye based on treatment usage. Results We included 388 respondents: 97 respondents (25%) with mild, 80 (21%) with moderate, and 211 (54%) with severe dry eye. In all three groups, screen/reading time generally doubled during the pandemic. Reduced work-related efficiency was noted by a considerable proportion of respondents (moderate dry eye: 51%, mild: 39%, and severe: 38%). Compared with respondents with mild dry eye, respondents with moderate dry eye were considerably more likely to note worsening symptoms: eye pain (OR = 2.57, 95% CI 1.22–5.41), headache from eye symptoms (OR = 2.34, 95% CI 1.11–4.90), and difficulty concentrating because of eye symptoms (OR = 2.79, 95% CI 1.37–5.66). Respondents with moderate dry eye with Sjogren's syndrome were most likely to note these. Respondents with severe dry eye were more likely than respondents with mild dry eye to report losing access to dry eye-related treatments (OR = 2.62, 95% CI 1.36–5.03). Conclusions The COVID-19 pandemic-related eye strain may be impacting symptoms, performance, and ultimately employment, especially for those with moderate dry eye. This may be compounding the already-high dry eye-related societal burden. |
Databáze: | OpenAIRE |
Externí odkaz: |